These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells. Hildinger M; Baldi L; Stettler M; Wurm FM Biotechnol Lett; 2007 Nov; 29(11):1713-21. PubMed ID: 17636388 [TBL] [Abstract][Full Text] [Related]
36. Comparison of highly pure rAAV9 vector stocks produced in suspension by PEI transfection or HSV infection reveals striking quantitative and qualitative differences. Trivedi PD; Yu C; Chaudhuri P; Johnson EJ; Caton T; Adamson L; Byrne BJ; Paulk NK; Clément N Mol Ther Methods Clin Dev; 2022 Mar; 24():154-170. PubMed ID: 35071688 [TBL] [Abstract][Full Text] [Related]
37. Optimised helper virus-free production of high-quality adeno-associated virus vectors. Drittanti L; Jenny C; Poulard K; Samba A; Manceau P; Soria N; Vincent N; Danos O; Vega M J Gene Med; 2001; 3(1):59-71. PubMed ID: 11269337 [TBL] [Abstract][Full Text] [Related]
38. Towards a scalable bioprocess for rAAV production using a HeLa stable cell line. Escandell J; Moura F; Carvalho SB; Silva RJS; Correia R; Roldão A; Gomes-Alves P; Alves PM Biotechnol Bioeng; 2023 Sep; 120(9):2578-2587. PubMed ID: 37027346 [TBL] [Abstract][Full Text] [Related]
39. Novel strategy for generation and titration of recombinant adeno-associated virus vectors. Shiau AL; Liu PS; Wu CL J Virol; 2005 Jan; 79(1):193-201. PubMed ID: 15596815 [TBL] [Abstract][Full Text] [Related]
40. Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors. Farson D; Harding TC; Tao L; Liu J; Powell S; Vimal V; Yendluri S; Koprivnikar K; Ho K; Twitty C; Husak P; Lin A; Snyder RO; Donahue BA J Gene Med; 2004 Dec; 6(12):1369-81. PubMed ID: 15538729 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]